巨噬細胞炎性蛋白1α(MIP1a)單克隆抗體
Monoclonal Antibody to Macrophage Inflammatory Protein 1 Alpha (MIP1a)
CCL3; MIP1-A; SCYA3; Chemokine C-C-Motif Ligand 3; Small Inducible Cytokine A3; Homologous To Mouse Mip-1a; Tonsillar Lymphocyte LD78 Alpha Protein
- 編號UMAA092Hu21
- 物種Homo sapiens (Human，人) 相同的名稱，不同的物種。
- 來源單抗制備
- 宿主小鼠
- 效價(克隆號)C13
- Ig亞型 IgG
- 純化方式抗原特異性親和純化
- 標記物無標記物
- 免疫原 -
- 緩沖液成份磷酸鹽緩沖液（pH7.4,含有0.02% NaN3和50%甘油）
- 性狀液體
- 濃度1mg/mL
- 且適物種-
- 應(yīng)用WB
如果抗體需用于流式細胞術(shù)，請參見流式抗體。 - 下載 英文說明書 中文說明書
- 規(guī)格 20μl100μl 200μl 1ml 10ml
- 價格 ¥ 266 ¥ 620 ¥ 885 ¥ 2213 ¥ 8850
- 欲了解實際交易價格和更多情況，請與當?shù)亟?jīng)銷商聯(lián)系!
-
產(chǎn)品包裝(模擬)
-
產(chǎn)品包裝(模擬)
-
Western Blot; Samples: Lane1: THP1 treated with 80nM PMA overnight, replacing the culture medium with 100ng/ml LPS for 6 hours, and finally adding 2μg/ml monensin for 3 hours, cell precipitation; Lane2: Untreated THP1 cell lysate;
Primary Ab: 0.3μg/ml Mouse Anti-Human MIP1a Antibody
Second Ab: 0.2μg/ml HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody
(Catalog: SAA544Mu19)
-
通過ISO 9001、ISO 13485質(zhì)量體系認證
特異性
該抗體是針對MIP1a的小鼠單克隆抗體。在免疫組織化學(xué)染色和免疫印跡實驗中能識別MIP1a。
用法
Western blotting: 0.1-2μg/mL;
Immunohistochemistry: 5-20μg/mL;
Immunocytochemistry: 5-20μg/mL;
Optimal working dilutions must be determined by end user.
儲存
經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復(fù)凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當?shù)臈l件下存儲，損失率低于5%。
贈品
增值服務(wù)
相關(guān)產(chǎn)品
| 編號 | 適用物種：Homo sapiens (Human，人) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| URPA092Hu01 | 巨噬細胞炎性蛋白1α(MIP1a)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| UAPA092Hu01 | 巨噬細胞炎性蛋白1α(MIP1a)活性蛋白 | Cell?culture;?Activity?Assays. |
| UAPA092Hu61 | 巨噬細胞炎性蛋白1α(MIP1a)活性蛋白 | Cell?culture;?Activity?Assays. |
| UEPA092Hu61 | 巨噬細胞炎性蛋白1α(MIP1a)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| UEPA092Hu51 | 巨噬細胞炎性蛋白1α(MIP1a)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| UPAA092Hu07 | 巨噬細胞炎性蛋白1α(MIP1a)多克隆抗體 | WB; IHC; ICC; IP. |
| UPAA092Hu01 | 巨噬細胞炎性蛋白1α(MIP1a)多克隆抗體 | IHC |
| UPAA092Hu06 | 巨噬細胞炎性蛋白1α(MIP1a)多克隆抗體 | WB; IHC; ICC; IP. |
| UMAA092Hu22 | 巨噬細胞炎性蛋白1α(MIP1a)單克隆抗體 | WB |
| UMAA092Hu21 | 巨噬細胞炎性蛋白1α(MIP1a)單克隆抗體 | WB |
| USEA092Hu | 巨噬細胞炎性蛋白1α(MIP1a)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| USCA092Hu | 巨噬細胞炎性蛋白1α(MIP1a)檢測試劑盒(化學(xué)發(fā)光免疫分析法) | Chemiluminescent immunoassay for Antigen Detection. |
| ULMA092Hu | 巨噬細胞炎性蛋白1α(MIP1a)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
| UKSA092Hu01 | 巨噬細胞炎性蛋白1α(MIP1a)檢測試劑盒DIY材料(酶聯(lián)免疫吸附試驗法) | Main materials for "Do It (ELISA Kit) Yourself". |
| UPGA092Hu01 | 巨噬細胞炎性蛋白1α(MIP1a)引物對 | PCR |
參考文獻
| 雜志 | 參考文獻 |
| Inhalation Toxicology | Age influence on hypersensitivity pneumonitis induced in mice by exposure to Pantoea agglomerans [Pubmed: 24044680] |
| Scientific Reports | The Transcriptional Foundations of Sp110-mediated Macrophage (RAW264. 7) Resistance to Mycobacterium tuberculosis H37Ra [Pubmed:26912204] |
| ActaMedicaMediterranea | CIRCULATING MACROPHAGE INFLAMMATORY PROTEIN-1 ALPHA (MIP1-Α) AS A POTENTIAL BIOMARKER FOR THE DIAGNOSIS OF PATIENTS WITH … [57e97ac908aeb34bc08fd41a.pdf] |
| National Natural Scientific | Role of Gut-Derived Endotoxin on Type I Collagen Production in the Rat Pancreas after Chronic Alcohol Exposure [pubmed:29121396] |
| Pharmacological Reports | Changes in the concentrations of inflammatory and oxidative status biomediators (MIP-1 α, PMN elastase, MDA, and IL-12) in depressed patients with and without posttraumatic stress disorder [10.1016/j.pharep.2017.08.008] |
| NPG?Asia?Materials | Molybdenum disulfide/graphene oxide nanocomposites show favorable lung targeting and enhanced drug loading/tumor-killing efficacy with improved?… [Articles:am2017225] |
| Journal of Immunology?Research | Therapeutic Potential of Pien Tze Huang on Experimental Autoimmune Encephalomyelitis Rat [Pubmed:29682587] |
| Journal of Immunology?Research | Cathelicidin LL-37 affects surface and intracellular Toll-like receptor expression in tissue mast cells [Pubmed:29670923] |
| Pharmacological Reports | Changes in the concentrations of inflammatory and oxidative status biomediators (MIP-1 α, PMN elastase, MDA, and IL-12) in depressed patients with and without?… [Pubmed:29339257] |
| Journal?of?Food?Science | CQPC06 Activity Prevents Dextran Sulfate Sodium‐Induced Colitis by Regulating the IL‐8 Pathway [Doi: 10.1111/1750-3841.14346] |
| Biochemical and Biophysical Research Communications | The anti-inflammatory and anti-oxidative effects of conbercept in treatment of macular edema secondary to retinal vein occlusion [Pubmed: 30558792] |
| LIFE SCIENCES | Intravitreal conbercept improves outcome of proliferative diabetic retinopathy through inhibiting inflammation and oxidative stress [Pubmed: 33227274] |
| ACTA PHARMACOLOGICA SINICA | α-Galactosylceramide and its analog OCH differentially affect the pathogenesis of ISO-induced cardiac injury in mice [Pubmed: 32973325] |
| Life Sci | PIGU promotes hepatocellular carcinoma progression through activating NF-κB pathway and increasing immune escape [Pubmed: 32971102] |
| Nature Communications | A vaccine-based nanosystem for initiating innate immunity and improving tumor immunotherapy [Pubmed: 32332752] |
| Neoplasia | PDIA6 promotes pancreatic cancer progression and immune escape through CSN5-mediated deubiquitination of β-catenin and PD-L1 [34325342] |
留言咨詢
